Karyopharm Therapeutics reported $3.94M in Stock for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Amgen AMGN:US $ 4152M 37M
Biocryst Pharmaceuticals BCRX:US $ 13.66M 3.82M
Bristol Myers Squibb BMY:US $ 2163M 26M
Eli Lilly And LLY:US $ 3907.4M 82.5M
Epizyme EPZM:US 1.52M 447K
GlaxoSmithKline GSK:LN 6244M 86M
Karyopharm Therapeutics KPTI:US $ 3.94M 38K
Nektar Therapeutics NKTR:US $ 15.33M 0.71M
Novartis NOVN:VX SF 6885M 226M
Regeneron Pharmaceuticals REGN:US $ 1550.1M 433.8M
Takeda 4502:JP Y 783476M 4328M
Ultragenyx Pharmaceutical RARE:US $ 15.19M 0.11M
YTE INCY:US $ 21.3M 4.63M